OAR 855-019-0205
Duty to Report

(1)

Failure to answer completely, accurately and honestly, all questions on the application form for licensure or renewal of licensure is grounds for discipline.

(2)

Failure to disclose any arrest for a felony or misdemeanor, or any indictment for a felony may result in denial of the application.

(3)

A pharmacist must report to the Board within 10 days if they:

(a)

Are convicted of a misdemeanor or a felony; or

(b)

If they are arrested for a felony.

(4)

A pharmacist who has reasonable cause to believe that another licensee (of the Board or any other Health Professional Regulatory Board) has engaged in prohibited or unprofessional conduct as these terms are defined in OAR 855-006-0005 (Definitions), must report that conduct to the board responsible for the licensee who is believed to have engaged in the conduct. The reporting pharmacist shall report the conduct without undue delay, but in no event later than 10 working days after the pharmacist learns of the conduct unless federal laws relating to confidentiality or the protection of health information prohibit disclosure.

(5)

A pharmacist who reports to a board in good faith as required by section (4) of this rule is immune from civil liability for making the report.

(6)

A pharmacist who has reasonable grounds to believe that any violation of these rules has occurred, must notify the Board within 10 days. However, in the event of a significant drug loss or violation related to drug theft, the pharmacist shall notify the Board within one (1) business day.

(7)

A pharmacist must notify the Board in writing, within 15 days, of any change in e-mail address, employment location or residence address.

Source: Rule 855-019-0205 — Duty to Report, https://secure.­sos.­state.­or.­us/oard/view.­action?ruleNumber=855-019-0205.

855‑019‑0100
Application 855‑019‑0110
Definitions 855‑019‑0120
Licensure 855‑019‑0122
Renewal of Licensure as a Pharmacist 855‑019‑0123
Liability Limitations for Volunteers 855‑019‑0125
Coaching from Board and Staff 855‑019‑0130
Licensure by Reciprocity 855‑019‑0140
NAPLEX Score Transfer 855‑019‑0150
Foreign Pharmacy Graduates 855‑019‑0160
Nuclear Pharmacists 855‑019‑0170
Reinstatement of License 855‑019‑0171
Reinstatement of a Revoked or Surrendered License 855‑019‑0200
General Responsibilities of a Pharmacist 855‑019‑0205
Duty to Report 855‑019‑0210
Duties of the Pharmacist Receiving a Prescription 855‑019‑0220
Drug Utilization Review (DUR) 855‑019‑0230
Counseling 855‑019‑0240
Consulting Pharmacist Practice 855‑019‑0250
Medication Therapy Management 855‑019‑0260
Collaborative Drug Therapy Management 855‑019‑0265
Administration of Drugs 855‑019‑0270
Immunization Qualifications 855‑019‑0280
Immunization Protocols, Policies and Procedures 855‑019‑0290
Immunization Record Keeping and Reporting 855‑019‑0300
Duties of a Pharmacist-in-Charge 855‑019‑0310
Grounds for Discipline 855‑019‑0400
Contraceptives - Purpose 855‑019‑0405
Contraceptives - Definitions 855‑019‑0410
Prescriptive Practice Consultation 855‑019‑0415
Contraceptive - Training Program 855‑019‑0425
Contraceptive - Procedural Mandates 855‑019‑0430
Contraceptive - Prohibited Practices 855‑019‑0435
Contraceptive - Records 855‑019‑0460
Naloxone - Delivery of Care and Prescribing 855‑019‑0470
Emergency Insulin
Last Updated

Jun. 8, 2021

Rule 855-019-0205’s source at or​.us